23andMe Holding Co. (ME)
Largest Insider Buys in Sector
ME Stock Price History Chart
ME Stock Performance
About 23andMe Holding Co.
23andMe Holding Co. operates as a consumer genetics testing company. It operates through two segments, Consumer & Research Services and Therapeutics. The Consumer & Research Services segment provides a suite of genetic reports, including information on customers' genetic ancestral origins, personal genetic health risks, and chances of passing on certain rare carrier conditions to their children, as well as reports on how genetics can impact responses to medications based on genetic testing of a saliva sample through its spit kit. The …
Insider Activity of 23andMe Holding Co.
Over the last 12 months, insiders at 23andMe Holding Co. have bought $0 and sold $310,795 worth of 23andMe Holding Co. stock.
On average, over the past 5 years, insiders at 23andMe Holding Co. have bought $1.83M and sold $339,482 worth of stock each year.
There was no buying activity among insiders over the last 12 months.
The last purchase of 11,467 shares for transaction amount of $50,558 was made by Lovell Evan () on 2022‑03‑10.
List of Insider Buy and Sell Transactions, 23andMe Holding Co.
| 2024-05-02 | Sale | Chief Administrative Officer | 38,551 0.0078% | $0.49 | $19,048 | -25.97% | ||
| 2024-04-18 | Sale | Chief Administrative Officer | 38,548 0.0074% | $0.47 | $18,148 | -23.15% | ||
| 2024-04-04 | Sale | Chief Administrative Officer | 38,548 0.0085% | $0.50 | $19,282 | -16.30% | ||
| 2024-03-21 | Sale | Chief Administrative Officer | 38,548 0.0085% | $0.46 | $17,894 | -8.12% | ||
| 2024-03-07 | Sale | Chief Administrative Officer | 38,548 0.0078% | $0.53 | $20,430 | -25.02% | ||
| 2024-02-22 | Sale | Chief Administrative Officer | 38,548 0.0123% | $0.61 | $23,325 | -30.25% | ||
| 2024-02-15 | Sale | Chief Administrative Officer | 38,548 0.0083% | $0.78 | $30,210 | -47.68% | ||
| 2024-01-25 | Sale | Chief Administrative Officer | 38,548 0.0078% | $0.73 | $27,997 | -40.53% | ||
| 2024-01-11 | Sale | Chief Administrative Officer | 38,548 0.0081% | $0.72 | $27,581 | -37.38% | ||
| 2023-12-28 | Sale | Chief Administrative Officer | 38,548 0.0081% | $0.93 | $35,904 | -51.48% | ||
| 2023-12-14 | Sale | Chief Administrative Officer | 38,548 0.0081% | $0.97 | $37,222 | -51.60% | ||
| 2023-11-30 | Sale | Chief Administrative Officer | 38,548 0.0082% | $0.88 | $33,753 | -45.73% | ||
| 2023-11-16 | Sale | Chief Administrative Officer | 38,548 0.0083% | $0.77 | $29,732 | -38.20% | ||
| 2023-11-02 | Sale | Chief Administrative Officer | 38,548 0.008% | $0.87 | $33,437 | -45.21% | ||
| 2023-10-19 | Sale | Chief Administrative Officer | 38,548 0.0081% | $0.81 | $31,397 | -39.22% | ||
| 2023-10-05 | Sale | Chief Administrative Officer | 38,548 0.0072% | $0.84 | $32,407 | -41.30% | ||
| 2023-09-21 | Sale | Chief Administrative Officer | 38,548 0.0081% | $1.00 | $38,583 | -47.52% | ||
| 2023-09-07 | Sale | Chief Administrative Officer | 40,894 0.0085% | $1.06 | $43,483 | -48.33% | ||
| 2023-09-05 | Sale | Head of Therapeutics Discovery | 2,538 0.0006% | $1.08 | $2,741 | -44.90% | ||
| 2023-08-24 | Sale | Chief Administrative Officer | 40,894 0.0078% | $1.05 | $43,119 | -41.48% |
Insider Historical Profitability
| BROWN DOUGLAS R | director | 100000 0.3658% | $3.10 | 2 | 0 | |
| Lockhart James B. III | director | 50000 0.1829% | $3.10 | 1 | 0 | |
| Briggs Teresa | director | 25000 0.0915% | $3.10 | 1 | 0 | |
| Lovell Evan | 11467 0.042% | $3.10 | 2 | 0 | <0.0001% | |
| Bayliss Joshua | Chief Executive Officer | 50 0.0002% | $3.10 | 1 | 0 |
Institutional Investor Ownership
| BlackRock | $11.47M | 4.4 | 21.56M | -4.04% | -$483,356.61 | <0.0001 | |
| Newview Capital Partners I Llc | $10.31M | 3.97 | 19.46M | 0% | +$0 | 8.96 | |
| The Vanguard Group | $8.68M | 3.33 | 16.31M | -27.68% | -$3.32M | <0.0001 | |
| Euclidean Capital Llc | $5.45M | 2.09 | 10.24M | 0% | +$0 | 0.7 | |
| Geode Capital Management | $3.98M | 1.53 | 7.48M | +6.02% | +$225,979.46 | <0.0001 |